- Johns Hopkins Medicine Summary: People with pre-diabetes who lose roughly 10 percent of their body weight within six months of diagnosis dramatically reduce their risk of developing type 2 diabetes over the next three years, according to new research.
- Global epidemiology of prediabetes - present and future perspectives. - Abstract - Europe PMC
- Cukorbetegség 7
- New Insights into the Biological and Pharmaceutical Properties of Royal Jelly
- Выходит, они следили за нами.
- - Вот тебе за то, что же после того, как мы появились всадила три пули в его Стражи встречая очередной вагончик со свежим запасом.
Go to: References 1. Prediabetes: a high-risk state for diabetes development.
Diabetes Prevention Program Research Group The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention program. Diabet Med. Diabetes Care.
Int J Mol Sci. Published online Jan 8. Copyright © by the authors. This article has been cited by other articles in PMC. Abstract Royal jelly RJ is a yellowish-white and acidic secretion of hypopharyngeal and mandibular glands of nurse bees used to feed young worker larvae during the first three days and the entire life of queen bees.
Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. Arq Bras Endocrinol Metab International diabetes federation: IDF diabetes atlas - 8th edition, American Diabetes Association.
Prevention or delay of type 2 diabetes: standards of medical Care in Diabetes Classification and diagnosis of diabetes: standards of medical Care in Diabetes Prevalence of pre-diabetes across ethnicities: a review of impaired fasting glucose IFG and impaired glucose tolerance IGT for classification of Dysglycaemia.
Insights Nutr Metabol— The epidemic of pre-diabetes: the medicine and the politics. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Diabetes Prevention Program Research Group HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.
Prevalence of prediabetes according to hemoglobin A1c versus fasting plasma glucose criteria in healthy adults. Acta Diabetol.
Ethn Dis. Lancet Diabetes Endocrinol. Diabetes in North America and the Caribbean: an update.
Diabetes Res Clin Pract. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ.